Venkor Corporation announces filing of Patent application for novel delivery formulation for nano-micro suspension drugs and biologics

Venkor Corporation announces filing of Patent application for novel delivery formulation for nano-micro suspension drugs and biologics
PRESS RELEASE,<br />February 25, 2019<br />Venkor Corporation, a Maryland Company, is pleased to announce filing of Patent application on<br />“FAST MELT SOLID ORAL COMPOSITIONS AND OTHER DELIVERY FORMS OF NANO-MICRO SUSPENSION DRUGS AND BIOLOGICS<br />The invention relates generally to the formulation and process or conversion of any pharmaceutical,...

PRESS RELEASE,

February 25, 2019

Venkor Corporation, a Maryland Company,  is pleased to announce filing of Patent application on

“FAST MELT SOLID ORAL COMPOSITIONS AND OTHER DELIVERY FORMS OF NANO-MICRO SUSPENSION DRUGS AND BIOLOGICS

  • The invention relates generally to the formulation and process or conversion of any pharmaceutical, biopharmaceutical or dietary supplements, foods in liquid dosage form containing insoluble or soluble solids in the form of nano-micro particle/ beads size range to a solid dosage form or delivery form.
  • It involves the conversion of aqueous and non-aqueous liquid suspensions containing nano-micro drug and biologic beads with the Entrap technology, a unique formulation and process to dry particles delivery form.
  • Applications include formulation of delivery forms for human and animal healthcare like Fast melt beads, Rapid melts, Wafer chew melts,  Modified and targeted release dosage forms, Dry powders for injections, oral solutions and oral suspensions which can be reconstituted to suitable delivery forms.
  • Products have accurate dosing, better patience compliance, improved bioavailability, good stability and organoleptic properties, and are easy to administer and portable when compared to available dosage forms like suspension or solution.
  • Initial product application include Weight Gain management therapeutic category product Megestrol acetate suspension with nanoparticles to Orally disintegrating dosage forms.  Applications also include other therapeutic categories -Metabolic disorders, Respiratory, Cardio, CNS, GI, Infectious, Immunology, Male health, Women’s health, UTI and others.

Venkor corporation, a Maryland company is a specialty Drug Delivery company, and is a  majority shareholder in Venkor Pharmaceuticals Inc., Venkor Specialty Products Inc., (both Virginia companies) and Chantilly Biopharma Pvt. Ltd (India)

Contacts: Subraman Cherukuri, CEO of Venkor Corporation, Tel: 1-703-932-3840, Email: src43y@venkorsp.comsrc43y@ymail.com